Physician profile
Charbel E Chalouhy
NPI 1497157770
$6,275.52
in general payments reported to CMS, 2019-2025
13 companies · $1,466 in 2025
The $1,466 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $606 · 2023: $1,062 · 2024: $3,141 · 2025: $1,466.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,669.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,015.64 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Cap |
| Coloplast Corp | $1,121.84 | 2022-2025 | Titan |
| Kerecis Limited | $733.05 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ethicon US, LLC | $464.92 | 2022-2025 | Echelon Flex, Echelon; Endopath, Enseal |
| Boston Scientific Corporation | $457.70 | 2022-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Teleflex LLC | $337.18 | 2023-2025 | Barrigel, Urolift |
| Davol INC. | $281.37 | 2022-2024 | Arista Ah Flexitip |
| Medtronic, INC. | $203.88 | 2024 | Signia |
| Becton, Dickinson and Company | $166.66 | 2025 | Avitene Ultrafoam |
| Calyxo, INC. | $149.56 | 2024 | Cvac Aspiration System |
| Axonics, INC. | $126.85 | 2022 | |
| Progenics Pharmaceuticals, INC. | $123.78 | 2024 | |
| Rigicon,INC. | $93.09 | 2024 | Rigi10 Malleable Penile Prosthesis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charbel Chalouhy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.